Pfizer will sell nearly two dozen of its patent-protected drugs and vaccines at not-for-profit prices to some of the world’s poorest countries
Albert Bourla tells WSJ CEO Council that Pfizer was effective in delivering vaccines to poorer countries at cost but it could've done better in education efforts by partnering with more NGOs. Photo: Ralph Alswang for The Wall Street JournalInc. will sell nearly two dozen of its patent-protected drugs and vaccines at not-for-profit prices to some of the world’s poorest countries.
Under the program, Pfizer will begin shipping the medicines first to Ghana, Malawi, Rwanda, Senegal and Uganda before the end of this year, Chief Executive
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
U.S. FDA sets June meeting dates for Moderna, Pfizer small children COVID-19 vaccinesThe U.S. Food and Drug Administration set June 14-15 as the new meeting date to review Moderna Inc's emergency authorization request for its COVID-19 vaccine for children aged 6 months to 5 years and Pfizer Inc's vaccine for those aged 6 months through 4 years.
Weiterlesen »
3 doses of COVID vaccine are effective for kids under 5, Pfizer saysThe long-awaited findings bring the vaccine one step closer to a reality for parents of children ages 6 months to 4 years — the only group that remains ineligible for vaccination.
Weiterlesen »
Pfizer says 3 COVID shots protect children under 5Three doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5, the company announced Monday. Pfizer plans to give the data to U.S. regulators later this week in…
Weiterlesen »
Pfizer Says Their COVID-19 Vaccine For Kids Under 5 Is 80% Effective Against OmicronPfizer said in preliminary findings in a subset of a clinical trial indicate that 3 doses of the vaccine are 80% effective in preventing symptomatic infection.
Weiterlesen »
Pfizer/BioNTech say 3 COVID shots elicit good response in children under 5Drugmakers Pfizer and BioNTech said on Monday that three doses of their COVID-19 vaccine generated a strong immune response in children under age 5 and was safe and well-tolerated in their clinical trial.
Weiterlesen »
Pfizer says 3 COVID shots protect children under 5Three doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5, the company said Monday, another step toward shots for the littlest kids possibly beginning in early summer.
Weiterlesen »